Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AKR-963 in severe hypertriglyceridemia
NCT01229566Phase 3Unknown
- Sponsor
- Trygg Pharma
- Start
- Oct 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3-acid ethyl esters in hypertriglyceridemia, sponsored by Trygg Pharma. Status: unknown.
02
Drugs
omega-3-acid ethyl esters
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT01229566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229566.